ϟ
DOI: 10.1093/annonc/mdu112
¤ OpenAccess: Hybrid
This work has “Hybrid” OA status. This means it is free under an open license in a toll-access journal.
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
Sherene Loi,Stefan Michiels,Roberto Salgado,Nicolas Sirtaine,Vinu José,Debora Fumagalli,Pirkko‐Liisa Kellokumpu‐Lehtinen,Petri Bono,Vesa Kataja,Christine Desmedt,Martine Piccart,Sibylle Loibl,Carsten Denkert,Mark J. Smyth,Heikki Joensuu,Christos Sotiriou
Medicine
Trastuzumab
Oncology
2014
Loading...
- MLA
- APA
- Chicago
- IEEE
- Harvard
- BibTeX
Cite this:
Generate Citation
“Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial” is a paper by Sherene Loi Stefan Michiels Roberto Salgado Nicolas Sirtaine Vinu José Debora Fumagalli Pirkko‐Liisa Kellokumpu‐Lehtinen Petri Bono Vesa Kataja Christine Desmedt Martine Piccart Sibylle Loibl Carsten Denkert Mark J. Smyth Heikki Joensuu Christos Sotiriou published in 2014. It has an Open Access status of “hybrid”. You can read and download a PDF Full Text of this paper here.